STOCK TITAN

Dror Ortho-Design Stock Price, News & Analysis

DROR OTC

Welcome to our dedicated page for Dror Ortho-Design news (Ticker: DROR), a resource for investors and traders seeking the latest updates and insights on Dror Ortho-Design stock.

Dror Ortho-Design, Inc. (DROR) is an AI-based orthodontic platform company best known for its ZSmile smart aligner technology, which uses pulsating air to straighten teeth while patients sleep or are at home. The DROR news feed on Stock Titan aggregates company announcements, clinical and regulatory updates, financing disclosures, and product-related developments that shape the outlook for this orthodontic technology business.

Readers can follow news about the ZSmile platform’s progress, including user experience trials, regulatory milestones such as Israeli AMAR approval, and the transition from first-generation systems to the second-generation solution. Coverage also includes updates on Dror’s partnerships with medical device developers and manufacturers, which the company describes as important for advancing hardware development and preparing for commercial production.

Because Dror positions ZSmile as an alternative to traditional clear aligners, its news often highlights patient survey results, usability findings, and the role of AI, smartphone-based scanning, and remote monitoring in orthodontic care. Press releases also discuss initiatives like the ZSmile Innovation Network, a community of dental professionals interested in adopting the platform’s single-aligner, pulsating-air treatment method.

In addition, investors can track capital markets developments through reports on private placements, debentures, and related warrants disclosed in Form 8-K filings and referenced in company announcements. By following DROR news, users can monitor how Dror’s technology, regulatory pathway, and financing activities evolve over time and how the company describes its efforts to change the aligner market.

Rhea-AI Summary

Dror (OTC PINK: DROR) announced that its second‑generation ZSmile platform received regulatory approval from the Israeli Ministry of Health AMAR division, clearing the way for a 2026 launch in Israel as a precursor to planned rollouts in the U.S. and Europe. ZSmile is a smart nighttime appliance using proprietary pulsating air technology to correct smiles overnight and includes a companion mobile app for real‑time monitoring and patient‑doctor communication. Management said the device aligns with treatment criteria validated in prior FDA‑ and CE‑cleared clinical trials and that the company will continue pursuing U.S. FDA and EU MDR clearances.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.5%
Tags
none
-
Rhea-AI Summary

Dror Ortho-Design (OTC PINK: DROR) has launched the ZSmile Innovation Network, a global initiative aimed at transforming orthodontic treatment. The company's breakthrough technology offers overnight smile correction, addressing major limitations of traditional aligners revealed in their survey of 1,000 users where 86% reported daily activity interference and 77% experienced discomfort.

The ZSmile platform utilizes innovative pulsating air technology through a single smart aligner worn during sleep, eliminating the need for multiple trays. The system features IoT connectivity, AI analytics, and real-time compliance monitoring, promising treatment completion in approximately half the time of conventional aligners. Survey data shows overwhelming patient interest, with 93% preferring overnight correction and 95% expressing interest in ZSmile's approach.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
35.14%
Tags
none
-
Rhea-AI Summary

Dror Ortho-Design (OTC PINK: DROR) has successfully completed user experience trials for its ZSmile platform, a second-generation orthodontic solution. The trial evaluated the platform's usability among patients, orthodontists, and dental professionals under real operating conditions.

The company's first-generation system, FDA-cleared in 2020, has treated over 250 patients across Israel and Europe. The new ZSmile platform features remote monitoring and patient management capabilities, tracking treatment compliance in real-time. Dror plans to begin manufacturing and distribution in Israel in the first half of 2025, pending regulatory approval.

A third-party survey of 1,000 clear aligner patients revealed that 74% reported interference with daily activities, 77% experienced discomfort, and 93% preferred a nighttime solution for teeth alignment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Dror Ortho-Design (OTC PINK: DROR) has announced a strategic partnership with Aran Research & Development to accelerate the development and commercialization of their ZSmile™ orthodontic treatment platform. Unlike traditional aligners using multiple plastic trays, ZSmile features a sophisticated control unit with silent air pump technology that delivers precise air pulses to a micro-balloon within their smart aligner.

The collaboration leverages Aran's expertise in electrical and mechanical engineering, electronics, materials science, industrial design, and manufacturing. This partnership eliminates the need for a large internal hardware development team while maintaining high product development standards. The companies are working together to establish robust production processes that meet FDA, CE, and ISO requirements for the upcoming commercial launch.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15%
Tags
partnership
-
Rhea-AI Summary

Dror Ortho-Design (OTC PINK: DROR) has released an updated investor presentation and video walkthrough on their website, highlighting their ZSmile platform. The company's proprietary solution uses pulsating air delivered through a single custom-made smart aligner to straighten teeth, primarily while patients sleep.

The ZSmile technology integrates AI capabilities through an app that enables dental professionals to remotely monitor and adjust treatment plans, reducing the need for office visits. The company aims to disrupt the traditional aligner market with this innovative approach.

Additionally, Dror filed a Form S-1 registration statement with the SEC on June 5, 2024, regarding the exchange of private shares for company shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Dror Ortho-Design (OTC PINK: DROR) has unveiled ZSmile, an innovative orthodontic solution using pulsating air through a single smart aligner for teeth straightening. The technology reduces plastic waste by up to 20 times compared to traditional aligners, which generate approximately 2.8 million kilograms of plastic waste annually. Traditional treatments require 10-20 aligners per patient, while ZSmile uses just one. The AI-powered system enables remote monitoring and promises treatment completion in half the time of conventional methods, while reducing in-office visits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Dror Ortho-Design (OTC PINK: DROR) has launched a user experience trial for its ZSMILE platform, an AI-based orthodontic solution that straightens teeth using pulsating air delivered by a single custom-made smart aligner. The trial, conducted in Israel, involves eligible patients, orthodontists, and dental professionals. ZSMILE is designed to be used while sleeping or discreetly at home.

The company's first-generation solution received CE mark in 2013 and FDA 510k clearance in 2020, having treated over 250 patients in Israel and Europe. The second-generation ZSMILE includes a mobile app for patients to track progress and a patient management system for doctors, utilizing AI technology for remote monitoring and treatment plan adjustments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Dror Ortho-Design (OTC PINK: DROR) has launched its new ZSMILE brand, replacing the former Aerodentis platform. ZSMILE is an AI-based orthodontic solution that uses a single smart aligner with pulsating air to straighten teeth while sleeping or at home. This innovative approach aims to revolutionize smile correction by offering a discreet and gentle alternative to traditional aligners.

The ZSMILE platform leverages AI technology to allow dentists and orthodontists to monitor and adjust treatment plans remotely, reducing the need for office visits. Dror's CEO, Lee Haddad, emphasized that ZSMILE aligns with their mission to provide convenient smile correction without the need for all-day plastic aligners.

Additionally, Dror's S-1 registration statement was declared effective by the SEC on June 14, 2024, with a final prospectus filed on June 17, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
117.07%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI

FAQ

What is the current stock price of Dror Ortho-Design (DROR)?

The current stock price of Dror Ortho-Design (DROR) is $0.0112 as of February 11, 2026.

What is the market cap of Dror Ortho-Design (DROR)?

The market cap of Dror Ortho-Design (DROR) is approximately 28.7M.
Dror Ortho-Design

OTC:DROR

DROR Rankings

DROR Stock Data

28.71M
601.46M
28.28%
10%
Personal Services
Consumer Cyclical
Link
Israel
Jerusalem

DROR RSS Feed